Imatinib Mesylate

Product Name : Imatinib Mesylate

CAS : 220127-57-1

Molecular Formula : C30H35N7O4S

Molecular Weight : 589.7 g/mol

Pharmaceutical Grade :

Therapeutic Category : BCR-ABL tyrosine kinase inhibitors


Global Calcium is one of the leading manufacturers and exporters of Imatinib Mesylate CAS no. 220127-57-1, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Imatinib Mesylate we hereby state the following facts about the drug:

Imatinib mesylate is a highly effective active pharmaceutical ingredient (API) revolutionizing the treatment of various types of cancer. As a tyrosine kinase inhibitor, it has shown remarkable success in combating chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other malignancies.

Mechanism of Action

By selectively inhibiting specific tyrosine kinases, including BCR-ABL, c-KIT, and PDGF-R, imatinib mesylate effectively disrupts cancer cell growth and survival. By suppressing the activity of these kinases, it halts the proliferation of malignant cells and promotes their programmed cell death.

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market